Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA lifts clinical hold on Invossa trials

July 9, 2018

Tegoprazan approved for the treatment of GERD in Korea

July 9, 2018

Bayer initiates first-in-human study with BAY-1830839

July 9, 2018

Incyte studies INCB-081776 for advanced solid tumors in phase I

July 9, 2018

Benitec and Axovant sign licensing agreement for BB-301 and partner on further gene therapy programs

July 9, 2018

Galapagos outlines phase II trial of GLPG-1205 in IPF

July 9, 2018

Phase II trial of ZGN-1061 in obesity and diabetes meets all primary objectives at interim analysis

July 9, 2018

New mutant EGFR inhibitors identified at Medshine Discovery

July 9, 2018

Laboratorios del Dr. Esteve discovers dual mu-opioid/sigma1R ligands

July 9, 2018

Dual GLP-1R/GCGR agonist may help to improve the control of postprandial glucose in type 2 diabetes

July 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...